Anti-Acid Drug Treatment Induces Changes in the Gut Microbiome Composition of Hemodialysis Patients
Open accessThe DOI matches its Crossref record; 49 of the 49 references it cites were found in a registry or an index.
Abstract
Anti-acid drugs, proton pump inhibitor (PPI) and histamine-2 blocker (H2-blocker), are commonly prescribed to treat gastrointestinal disorders. These anti-acid drugs alter gut microbiota in the general population, but their effects are not known in hemodialysis patients. Hence, we investigated the microbiota composition in hemodialysis patients treated with PPIs or H2-blocker. Among 193 hemodialysis patients, we identified 32 H2-blocker users, 23 PPI users, and 138 no anti-acid drug subjects. Fecal samples were obtained to analyze the gut microbiome using 16S RNA amplicon sequencing. Differences in the microbial composition of the H2-blocker users, PPI users, and controls were assessed using linear discriminant analysis effect size and the random forest algorithm. The species richness or evenness (α-diversity) was similar among the three groups, whereas the inter-individual diversity (β-diversity) was different between H2-blocker users, PPI users, and controls. Hemodialysis patients treated with H2-blocker and PPIs had a higher microbial dysbiosis index than the controls, with a significant increase in the genera Provetella 2, Phascolarctobacterium, Christensenellaceae R-7 group, and Eubacterium oxidoreducens group in H2-blocker users, and Streptococcus and Veillonella in PPI users. In addition, compared to the H2-blocker users, there was a significant enrichment of the genera Streptococcus in PPI users, as confirmed by the random forest analysis and the confounder-adjusted regression model. In conclusion, PPIs significantly changed the gut microbiota composition in hemodialysis patients compared to H2-blocker users or controls. Importantly, the Streptococcus genus was significantly increased in PPI treatment. These findings caution against the overuse of PPIs.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PPIs, for instance, enrich Firmicutes and oral taxa like Streptococcus salivarius and Micrococcaceae, expand Veillonella and Enterocloster, and reduce overall diversity, a profile linked to Clostridioides difficile infection and adverse metabolic shifts.43,92–97”
From Gut dysbiosis in oncology: a risk factor for immunoresistance (2026) · doi:10.1038/s41422-025-01212-6 · cites this paper as [95]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Love, M. I., Huber, W., & Anders, S. (2014) · Genome Biology · doi:10.1186/s13059-014-0550-8 · Cited by 95,106 · cited 1×
“The differential abundance analysis was also analyzed using DESeq2 methods [22].”
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192 · cited 1×
“The bacterial community difference between H2-blocker users, PPI users, and controls by the linear discriminant analysis (LDA) of effect size (LEfSe) analysis [19], heat tree method [20], hierarchical clustering heat map, and random forest method [21].”
MethodThe Human Intestinal Microbiome in Health and Disease
Lynch, S. V., & Pedersen, O. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1600266 · Cited by 3,637 · cited 1×
“Gut microbes have key roles in metabolic, nutritional, and physiological processes in the human body [39].”
BackgroundRandom Forest: A Classification and Regression Tool for Compound Classification and QSAR Modeling
Svetnik, V., Liaw, A., Tong, C., Culberson, J. C., Sheridan, R. P., & Feuston, B. P. (2003) · Journal of Chemical Information and Computer Sciences · doi:10.1021/ci034160g · Cited by 3,573 · cited 1×
“The bacterial community difference between H2-blocker users, PPI users, and controls by the linear discriminant analysis (LDA) of effect size (LEfSe) analysis [19], heat tree method [20], hierarchical clustering heat map, and random forest method [21].”
MethodThe Treatment-Naive Microbiome in New-Onset Crohn’s Disease
Gevers, D., Kugathasan, S., Denson, L. A., Vázquez-Baeza, Y., Van Treuren, W., Ren, B., Schwager, E., Knights, D., Song, S. J., Yassour, M., et al. (2014) · Cell Host & Microbe · doi:10.1016/j.chom.2014.02.005 · Cited by 3,220 · cited 4×
“However, HD patients taking H2-blocker or PPI had a higher MDI than controls (Figure 1B), with a significant difference in their microbiota composition (Figure 2).”
MethodInfluentialTransitions in bacterial communities along the 2000 km salinity gradient of the Baltic Sea
Herlemann, D. P. R., Labrenz, M., Jürgens, K., Bertilsson, S., Waniek, J. J., & Andersson, A. F. (2011) · The ISME Journal · doi:10.1038/ismej.2011.41 · Cited by 2,885 · cited 1×
“The amplicon library was constructed by amplifying the variable regions 3 and 4 (V3-V4) of the 16S rRNA gene using barcode-indexed PCR primers (341F and 805R) [16] and the 16S amplicons were sequenced (300 bp paired-end) by an Illumina MiSeq sequencer by Genomics BioScience (Taipei, Taiwan).”
MethodLozupone, C. A., Hamady, M., Kelley, S. T., & Knight, R. (2007) · Applied and Environmental Microbiology · doi:10.1128/aem.01996-06 · Cited by 2,656 · cited 1×
“, diversity in bacterial composition between samples) was estimated by computing the Bray–Curtis distance, Jensen–Shannon divergence, or Jaccard index and visualized through a principal coordinates analysis (PCoA) to evaluate the difference in bacterial communities between anti-acid drug users and controls [17].”
MethodDhariwal, A., Chong, J., Habib, S., King, I. L., Agellon, L. B., & Xia, J. (2017) · Nucleic Acids Research · doi:10.1093/nar/gkx295 · Cited by 1,885
Chong, J., Liu, P., Zhou, G., & Xia, J. (2020) · Nature Protocols · doi:10.1038/s41596-019-0264-1 · Cited by 1,702
Self-citationTax4Fun: predicting functional profiles from metagenomic 16S rRNA data
Aßhauer, K. P., Wemheuer, B., Daniel, R., & Meinicke, P. (2015) · Bioinformatics · doi:10.1093/bioinformatics/btv287 · Cited by 1,578 · cited 1×
“Predicted functional genes were aligned with the Kyoto Encyclopedia of Genes and Genomes (KEGG) database and annotated by KEGG orthology (KO) using the R “Tax4Fun” package [25].”
Method
Cited by
Gut OncoMicrobiome Signatures (GOMS) as next-generation biomarkers for cancer immunotherapy
Thomas, A. M., Fidelle, M., Routy, B., Kroemer, G., Wargo, J. A., Segata, N., & Zitvogel, L. (2023) · Nature Reviews Clinical Oncology · doi:10.1038/s41571-023-00785-8 · Cited by 141
Xia, B., Yang, M. G., Nguyen, L. H., He, Q., Zhen, J., Yu, Y., Di, M., Qin, X. S., Lu, K., Kuo, Z. C., et al. (2021) · Gastroenterology · doi:10.1053/j.gastro.2021.08.005 · Cited by 94
Meta-analysis of the effects of proton pump inhibitors on the human gut microbiota
Zhang, J., Zhang, C., Zhang, Q., Yu, L., Chen, W., Xue, Y., & Zhai, Q. (2023) · BMC Microbiology · doi:10.1186/s12866-023-02895-w · Cited by 74
Interplay between gut microbiota, bone health and vascular calcification in chronic kidney disease
Rodrigues, F. G., Ormanji, M. S., Heilberg, I. P., Bakker, S. J. L., & de Borst, M. H. (2021) · European Journal of Clinical Investigation · doi:10.1111/eci.13588 · Cited by 56
Potential effects of the most prescribed drugs on the microbiota-gut-brain-axis: A review
Garg, K., & Mohajeri, M. H. (2024) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2024.110883 · Cited by 34
“In addition, dysbiosis is observed in functional dyspepsia, with cirrhosis, haemodialysis, rheumatoid arthritis and cancer patients, who show specific increase in Streptococcus genus (Bajaj et al., 2018; Lin et al., 2021).”
Gut dysbiosis in oncology: a risk factor for immunoresistance
(2026) · doi:10.1038/s41422-025-01212-6 · Cited by 24
Gut Microbiota in Patients Receiving Dialysis: A Review
Lim, X., Ooi, L., Ding, U., Wu, H. H. L., & Chinnadurai, R. (2024) · Pathogens · doi:10.3390/pathogens13090801 · Cited by 25
“Notably, PPI users demonstrated a more pronounced enrichment in Streptococcus compared to H2 receptor antagonist users [54].”
BackgroundGastric acid suppressants and cognitive decline in people with or without cognitive impairment
Wu, C., Xiong, L. Y., Ouk, M., Rabin, J. S., Herrmann, N., Lanctôt, K. L., Kapral, M. K., Law, M., Cogo‐Moreira, H., Edwards, J. D., et al. (2022) · Alzheimer's & Dementia: Translational Research & Clinical Interventions · doi:10.1002/trc2.12243 · Cited by 13
Self-citationHu, L., Lai, C., Li, Y. H., Sun, R., Yang, H., Liu, X., & Yu, P. (2025) · npj Biofilms and Microbiomes · doi:10.1038/s41522-025-00848-x · Cited by 16
“One of the most prominent microbiota changes in PPIs users is the increased abundance of oral bacteria in the gut, including Streptococcus and Veillonella 11,32,44,59,61,71 – 73 .”
Multi-Omics Analysis Reveals Age-Related Microbial and Metabolite Alterations in Non-Human Primates
Chen, X., Liu, Y., Pu, J., Gui, S., Wang, D., Zhong, X., Tao, W., Chen, X., Chen, W., Chen, Y., et al. (2023) · Microorganisms · doi:10.3390/microorganisms11102406 · Cited by 10
“Prior studies noted a significant association between increased Eubacterium_oxidoreducens_group and decreased gastric acid secretion [48].”
BackgroundSingh, C., Singh, A., Singh, D., & Upadhyay, R. (2025) · Medicine in Microecology · doi:10.1016/j.medmic.2025.100121 · Cited by 13
Tomisaki, I., Harada, M., Sakano, S., Terado, M., Hamasuna, R., Harada, S., Matsumoto, H., Akasaka, S., Nagata, Y., Minato, A., et al. (2023) · International Journal of Urology · doi:10.1111/iju.15151 · Cited by 7
Madej, J., Atanassova, T., McGuire, S., Cohen, B., Weidner, M., Zhang, Y., & Horton, D. B. (2023) · Pediatric Allergy and Immunology · doi:10.1111/pai.14042 · Cited by 4
Fan, Y., Xiao, Y., Zhang, S., Bai, W., & Chen, J. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250129 · Cited by 4
“However, another studies reported that a significant increase of Christensenellaceae was suggested to identified as the microbial dysbiosis index in hemodialysis patients intervened with histamine-2 blocker or proton pump inhibitor [40] .”
Alizadeh, M. A., Wong, U., Siaton, B. C., Patil, S. A., George, L. A., Raufman, J., Scott, W. H., von Rosenvinge, E. C., Ravel, J., & Cross, R. K. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08478-7 · Cited by 4
Cohort Profile: Taiwan Kidney Outcome (TAKO) and Taiwan Kidney Outcome Omics (TAKOO) cohorts
Wu, P., Lin, M., Huang, T., Chuang, Y., Tsai, Y., Chen, S., Kuo, I., Tsai, W., Lin, H., Lee, T., et al. (2025) · International Journal of Epidemiology · doi:10.1093/ije/dyaf152 · Cited by 1
Self-citationThe symphony of kidney health: connecting diet, gut microbiome, bone and vasculature
Rodrigues, F. G. (2024) · University of Groningen research database (University of Groningen / Centre for Information Technology) · doi:10.33612/diss.938886885
Morikubo, H., Nagahama, T., Nagai, K., Yamazaki, H., & Kobayashi, T. (2024) · Inflammatory Intestinal Diseases · doi:10.1159/000541984
“Although H2RAs may affect the gut microbiota in the same manner, PPIs may alter the composition of the gut microbiota more signi fi cantly than H2RA [34], which may explain the difference between PPI and H2RA in the impact on the clinical course of IBD.”
Zhang, J., Zhang, C., Zhang, Q., Yu, L., Chen, W., Xue, Y., & Zhai, Q. (2023) · Figshare · doi:10.6084/m9.figshare.23542924
Sun, Y., Veccia, D., Song, G., & Waghray, N. (2026) · Journal of Personalized Medicine · doi:10.3390/jpm16040193
“Histamine-2 receptor antagonists (H2RAs), another class of acid-suppressive therapy, provide a clinically relevant active comparator, as they are prescribed for similar indications but exert less profound acid suppression and have more modest effects on the gut microbiome [13].”
Hsieh, H., Lee, W.-Y., Lin, C., Chen, C., Tsai, F.-J., You, B., Tien, N., Fang, Y., & Lim, Y.-P. (2026) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/20420188261442014
Fang, S., Yang, X., & Liu, F. (2026) · Frontiers in Medicine · doi:10.3389/fmed.2026.1959574
Metadata
- Authors
- Lin, Y.-T., Lin, T.-Y., Hung, S.-C., Liu, P.-Y., Wu, P.-H., Chuang, Y.-S., Hung, W.-C., Chiu, Y.-W., Kuo, M.-C., & Wu, C.-Y.
- Affiliations
- Kaohsiung Medical University (TW)
- Tzu Chi University (TW)
- National Taiwan University (TW)
- Kaohsiung Medical University Chung-Ho Memorial Hospital (TW)
- National Health Research Institutes (TW)
- Corresponding author
- Wu, Ping-Hsun
- ORCID
- Venue
- Microorganisms
- Publisher
- MDPI AG
- Published
- 2021-01-30
- Volume
- 9
- Issue
- 2
- Pages
- 286
- ISSN
- 2076-2607 (ISSN-L)
- PMC
- PMC7910989
- OpenAlex
- W3129141123
- Cited by
- 22
- References
- 49
- Citations by year
- 2026: 4 · 2025: 3 · 2024: 6 · 2023: 6 · 2022: 1 · 2021: 2
- FWCI
- 1.18
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Microorganisms (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Ministry of Science and Technology, Taiwan (MOST 106-2314-B-037-054, MOST 107-2314-B-037-104, and MOST 107-2314-B-037-098-MY3)
- Kaohsiung Medical University Hospital, Taiwan (KMUH105-5R15, KMUH106-6R17, KMUH106-6T03, KMUH107-7R16, KMUH107-7R78, KMUH108-8M11, and KMUH108-8R70)
- Kaohsiung Medical University, Taiwan (KMU-Q108024 and KMU-Q108027)
- NSYSU-KMU JOINT RESEARCH PROJECT (NSYSUKMU 105-I005 and NSYSUKMU 106-I005)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Dentistry › Periodontics › Oral microbiology and periodontitis research
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- proton pump inhibitors, H2 receptor antagonists, gut microbiota, hemodialysis patients, dysbiosis, Streptococcus, Phascolarctobacterium, Christensenellaceae, Veillonella, beta diversity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.